171 related articles for article (PubMed ID: 32632898)
21. Design, synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as anti-glioblastoma agents targeting the AKT pathway.
Szeliga M; Karpińska M; Rola R; Niewiadomy A
Bioorg Chem; 2020 Dec; 105():104362. PubMed ID: 33074121
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of antiangiogenic targeted toxins against glioblastoma multiforme.
Hall WA; Vallera DA
Neurosurg Focus; 2006 Apr; 20(4):E23. PubMed ID: 16709029
[TBL] [Abstract][Full Text] [Related]
23. NFκB inhibitors induce cell death in glioblastomas.
Zanotto-Filho A; Braganhol E; Schröder R; de Souza LH; Dalmolin RJ; Pasquali MA; Gelain DP; Battastini AM; Moreira JC
Biochem Pharmacol; 2011 Feb; 81(3):412-24. PubMed ID: 21040711
[TBL] [Abstract][Full Text] [Related]
24. Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma.
Ahir BK; Engelhard HH; Lakka SS
Mol Neurobiol; 2020 May; 57(5):2461-2478. PubMed ID: 32152825
[TBL] [Abstract][Full Text] [Related]
25. Aquaporin 1 elicits cell motility and coordinates vascular bed formation by downregulating thrombospondin type-1 domain-containing 7A in glioblastoma.
Oishi M; Munesue S; Harashima A; Nakada M; Yamamoto Y; Hayashi Y
Cancer Med; 2020 Jun; 9(11):3904-3917. PubMed ID: 32253832
[TBL] [Abstract][Full Text] [Related]
26. PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression.
Chou YC; Chang MY; Wang MJ; Yu FS; Liu HC; Harnod T; Hung CH; Lee HT; Chung JG
Oncol Rep; 2015 Nov; 34(5):2489-96. PubMed ID: 26352173
[TBL] [Abstract][Full Text] [Related]
27. Cyclooxygenase Inhibition Alters Proliferative, Migratory, and Invasive Properties of Human Glioblastoma Cells In Vitro.
Ferreira MT; Miyake JA; Gomes RN; Feitoza F; Stevannato PB; da Cunha AS; Serachi FO; Panagopoulos AT; Colquhoun A
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919029
[TBL] [Abstract][Full Text] [Related]
28. Estrogen-related receptor β activation and isoform shifting by cdc2-like kinase inhibition restricts migration and intracranial tumor growth in glioblastoma.
Tiek DM; Khatib SA; Trepicchio CJ; Heckler MM; Divekar SD; Sarkaria JN; Glasgow E; Riggins RB
FASEB J; 2019 Dec; 33(12):13476-13491. PubMed ID: 31570001
[TBL] [Abstract][Full Text] [Related]
29. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
[TBL] [Abstract][Full Text] [Related]
30. Efficient delivery of anti-miR-210 using Tachyplesin, a cell penetrating peptide, for glioblastoma treatment.
Jana A; Narula P; Chugh A; Kulshreshtha R
Int J Pharm; 2019 Dec; 572():118789. PubMed ID: 31726199
[TBL] [Abstract][Full Text] [Related]
31. Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.
Furuta T; Sabit H; Dong Y; Miyashita K; Kinoshita M; Uchiyama N; Hayashi Y; Hayashi Y; Minamoto T; Nakada M
Oncotarget; 2017 Apr; 8(14):22811-22824. PubMed ID: 28423558
[TBL] [Abstract][Full Text] [Related]
32. Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma.
Barone A; Sengupta R; Warrington NM; Smith E; Wen PY; Brekken RA; Romagnoli B; Douglas G; Chevalier E; Bauer MP; Dembowsky K; Piwnica-Worms D; Rubin JB
Oncotarget; 2014 Oct; 5(20):9811-22. PubMed ID: 25238146
[TBL] [Abstract][Full Text] [Related]
33. MiR-137 inhibits proliferation and angiogenesis of human glioblastoma cells by targeting EZH2.
Sun J; Zheng G; Gu Z; Guo Z
J Neurooncol; 2015 May; 122(3):481-9. PubMed ID: 25939439
[TBL] [Abstract][Full Text] [Related]
34. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of glioblastoma proliferation, invasion, and migration by Urolithin B through inducing G0/G1 arrest and targeting MMP-2/-9 expression and activity.
Eidizade F; Soukhtanloo M; Zhiani R; Mehrzad J; Mirzavi F
Biofactors; 2023 Mar; 49(2):379-389. PubMed ID: 36310375
[TBL] [Abstract][Full Text] [Related]
36. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia upregulates HIG2 expression and contributes to bevacizumab resistance in glioblastoma.
Mao XG; Wang C; Liu DY; Zhang X; Wang L; Yan M; Zhang W; Zhu J; Li ZC; Mi C; Tian JY; Hou GD; Miao SY; Song ZX; Li JC; Xue XY
Oncotarget; 2016 Jul; 7(30):47808-47820. PubMed ID: 27329597
[TBL] [Abstract][Full Text] [Related]
38. EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.
Su L; Guo W; Lou L; Nie S; Zhang Q; Liu Y; Chang Y; Zhang X; Li Y; Shen H
Mol Carcinog; 2020 May; 59(5):520-532. PubMed ID: 32134157
[TBL] [Abstract][Full Text] [Related]
39. CXCR4-STAT3 Axis Plays a Role in Tumor Cell Infiltration in an Orthotopic Mouse Glioblastoma Model.
Han JH; Yoon JS; Chang DY; Cho KG; Lim J; Kim SS; Suh-Kim H
Mol Cells; 2020 Jun; 43(6):539-550. PubMed ID: 32597394
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Rb and mTOR signaling associates with synergistic anticancer effect of palbociclib and erlotinib in glioblastoma cells.
Liu S; Tang Y; Yuan X; Yuan D; Liu J; Li B; Li Y
Invest New Drugs; 2018 Dec; 36(6):961-969. PubMed ID: 29508248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
